{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T09:46:56Z","timestamp":1764841616567,"version":"3.37.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.mehy.2009.05.043","type":"journal-article","created":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T08:26:30Z","timestamp":1246436790000},"page":"1008-1010","source":"Crossref","is-referenced-by-count":18,"title":["Activation of AMP-activated kinase as a strategy for managing autosomal dominant polycystic kidney disease"],"prefix":"10.1016","volume":"73","author":[{"given":"Mark F.","family":"McCarty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Barroso-Aranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Contreras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.mehy.2009.05.043_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1067\/mlc.2003.13","article-title":"Autosomal dominant polycystic kidney disease: molecular genetics and pathophysiology","volume":"141","author":"Sutters","year":"2003","journal-title":"J Lab Clin Med"},{"issue":"10","key":"10.1016\/j.mehy.2009.05.043_bib2","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/nm935","article-title":"Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist","volume":"9","author":"Gattone","year":"2003","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.mehy.2009.05.043_bib3","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1161\/01.RES.0000163278.68142.8a","article-title":"[Ca2+]i reduction increases cellular proliferation and apoptosis in vascular smooth muscle cells: relevance to the ADPKD phenotype","volume":"96","author":"Kip","year":"2005","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.mehy.2009.05.043_bib4","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1681\/ASN.2005060645","article-title":"Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells","volume":"17","author":"Yamaguchi","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"1 Pt 1","key":"10.1016\/j.mehy.2009.05.043_bib5","doi-asserted-by":"crossref","first-page":"C389","DOI":"10.1152\/ajpcell.1996.270.1.C389","article-title":"A role for CFTR in human autosomal dominant polycystic kidney disease","volume":"270","author":"Hanaoka","year":"1996","journal-title":"Am J Physiol"},{"issue":"1","key":"10.1016\/j.mehy.2009.05.043_bib6","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/ki.1996.304","article-title":"The cystic fibrosis transmembrane conductance regulator mediates transepithelial fluid secretion by human autosomal dominant polycystic kidney disease epithelium in vitro","volume":"50","author":"Davidow","year":"1996","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.mehy.2009.05.043_bib7","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1111\/j.1523-1755.2004.00967.x","article-title":"The relationship between cell proliferation, Cl-secretion, and renal cyst growth: a study using CFTR inhibitors","volume":"66","author":"Li","year":"2004","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.mehy.2009.05.043_bib8","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1681\/ASN.V641230","article-title":"An in vitro test of the cell stretch-proliferation hypothesis of renal cyst enlargement","volume":"6","author":"Tanner","year":"1995","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.mehy.2009.05.043_bib9","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/j.1523-1755.2005.00703.x","article-title":"Vasopressin antagonists in polycystic kidney disease","volume":"68","author":"Torres","year":"2005","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.mehy.2009.05.043_bib10","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1681\/ASN.2006030251","article-title":"Increased water intake decreases progression of polycystic kidney disease in the PCK rat","volume":"17","author":"Nagao","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"14","key":"10.1016\/j.mehy.2009.05.043_bib11","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1073\/pnas.0509694103","article-title":"The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease","volume":"103","author":"Shillingford","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.mehy.2009.05.043_bib12","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1681\/ASN.2004080660","article-title":"Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease","volume":"16","author":"Tao","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.mehy.2009.05.043_bib13","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/ndt\/gfi181","article-title":"Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD)","volume":"21","author":"Wahl","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.mehy.2009.05.043_bib14","doi-asserted-by":"crossref","first-page":"R251","DOI":"10.1093\/hmg\/ddi260","article-title":"Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways","volume":"14","author":"Kwiatkowski","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"Pt 3","key":"10.1016\/j.mehy.2009.05.043_bib15","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1042\/BJ20041888","article-title":"Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2)","volume":"388","author":"Rolfe","year":"2005","journal-title":"Biochem J"},{"issue":"2","key":"10.1016\/j.mehy.2009.05.043_bib16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cell.2005.02.031","article-title":"Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis","volume":"121","author":"Ma","year":"2005","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.mehy.2009.05.043_bib17","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/01.ftd.0000245377.93401.39","article-title":"Sirolimus \u2013 challenging current perspectives","volume":"28","author":"Buhaescu","year":"2006","journal-title":"Ther Drug Monit"},{"issue":"7","key":"10.1016\/j.mehy.2009.05.043_bib18","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1046\/j.1365-2230.2002.01148.x","article-title":"Calcineurin inhibitors and sirolimus: mechanisms of action and applications in dermatology","volume":"27","author":"Reynolds","year":"2002","journal-title":"Clin Exp Dermatol"},{"issue":"Pt 1","key":"10.1016\/j.mehy.2009.05.043_bib19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1113\/jphysiol.2006.108324","article-title":"AMPK and cell proliferation \u2013 AMPK as a therapeutic target for atherosclerosis and cancer","volume":"574","author":"Motoshima","year":"2006","journal-title":"J Physiol"},{"issue":"11","key":"10.1016\/j.mehy.2009.05.043_bib20","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1249\/01.mss.0000233796.16411.13","article-title":"Interaction between the AMP-activated protein kinase and mTOR signaling pathways","volume":"38","author":"Kimball","year":"2006","journal-title":"Med Sci Sports Exerc"},{"issue":"42","key":"10.1016\/j.mehy.2009.05.043_bib21","doi-asserted-by":"crossref","first-page":"43940","DOI":"10.1074\/jbc.M404421200","article-title":"Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species","volume":"279","author":"Zou","year":"2004","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.mehy.2009.05.043_bib22","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.2337\/diabetes.51.8.2420","article-title":"The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism","volume":"51","author":"Hawley","year":"2002","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.mehy.2009.05.043_bib23","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.2337\/diabetes.51.7.2074","article-title":"Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes","volume":"51","author":"Musi","year":"2002","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.mehy.2009.05.043_bib24","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.mehy.2009.05.043_bib25","doi-asserted-by":"crossref","first-page":"F617","DOI":"10.1152\/ajprenal.00278.2006","article-title":"A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy","volume":"292","author":"Lee","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"issue":"12","key":"10.1016\/j.mehy.2009.05.043_bib26","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1172\/JCI9622","article-title":"Inhibition of cystic fibrosis transmembrane conductance regulator by novel interaction with the metabolic sensor AMP-activated protein kinase","volume":"105","author":"Hallows","year":"2000","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.mehy.2009.05.043_bib27","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1074\/jbc.M210621200","article-title":"Regulation of channel gating by AMP-activated protein kinase modulates cystic fibrosis transmembrane conductance regulator activity in lung submucosal cells","volume":"278","author":"Hallows","year":"2003","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.mehy.2009.05.043_bib28","doi-asserted-by":"crossref","first-page":"C1297","DOI":"10.1152\/ajpcell.00227.2002","article-title":"Physiological modulation of CFTR activity by AMP-activated protein kinase in polarized T84 cells","volume":"284","author":"Hallows","year":"2003","journal-title":"Am J Physiol Cell Physiol"},{"issue":"5","key":"10.1016\/j.mehy.2009.05.043_bib29","doi-asserted-by":"crossref","first-page":"G850","DOI":"10.1152\/ajpgi.00077.2003","article-title":"Activation of AMP-activated protein kinase reduces cAMP-mediated epithelial chloride secretion","volume":"285","author":"Walker","year":"2003","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"5","key":"10.1016\/j.mehy.2009.05.043_bib30","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/01.mnh.0000174145.14798.64","article-title":"Emerging role of AMP-activated protein kinase in coupling membrane transport to cellular metabolism","volume":"14","author":"Hallows","year":"2005","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"3","key":"10.1016\/j.mehy.2009.05.043_bib31","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1161\/01.RES.0000256090.42690.05","article-title":"AMP-activated protein kinase in metabolic control and insulin signaling","volume":"100","author":"Towler","year":"2007","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.mehy.2009.05.043_bib32","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1365-2796.2005.01531.x","article-title":"Metformin improves endothelial function in patients with metabolic syndrome","volume":"258","author":"Vitale","year":"2005","journal-title":"J Intern Med"},{"issue":"5","key":"10.1016\/j.mehy.2009.05.043_bib33","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jacc.2006.04.088","article-title":"Effects of metformin on microvascular function and exercise tolerance in women with angina and normal coronary arteries: a randomized, double-blind, placebo-controlled study","volume":"48","author":"Jadhav","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.mehy.2009.05.043_bib34","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2337\/dc05-2146","article-title":"Metformin improves endothelial vascular reactivity in first-degree relatives of type 2 diabetic patients with metabolic syndrome and normal glucose tolerance","volume":"29","author":"de Aguiar","year":"2006","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.mehy.2009.05.043_bib35","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/pds.1443","article-title":"Coronary heart disease outcomes in patients receiving antidiabetic agents","volume":"16","author":"McAfee","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"10.1016\/j.mehy.2009.05.043_bib36","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1046\/j.1523-1755.2003.00236.x","article-title":"Endothelial dysfunction and reduced nitric oxide in resistance arteries in autosomal-dominant polycystic kidney disease","volume":"64","author":"Wang","year":"2003","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.mehy.2009.05.043_bib37","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.2460\/ajvr.1982.43.09.1594","article-title":"Effect of berberine on intestinal secretion mediated by Escherichia coli heat-stable enterotoxin in jejunum of pigs","volume":"43","author":"Zhu","year":"1982","journal-title":"Am J Vet Res"},{"issue":"5","key":"10.1016\/j.mehy.2009.05.043_bib38","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/infdis\/155.5.979","article-title":"Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and Vibrio cholerae","volume":"155","author":"Rabbani","year":"1987","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mehy.2009.05.043_bib39","doi-asserted-by":"crossref","unstructured":"Berberine. Altern Med Rev 2000; 5(2): 175\u2013177.","DOI":"10.1034\/j.1600-065X.2000.17715.x"},{"issue":"12","key":"10.1016\/j.mehy.2009.05.043_bib40","first-page":"711","article-title":"Therapeutic effect of berberine on 60 patients with type II diabetes mellitus and experimental research","volume":"8","author":"Ni","year":"1988","journal-title":"Zhong Xi Yi Jie He Za Zhi"},{"issue":"1","key":"10.1016\/j.mehy.2009.05.043_bib41","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jep.2006.04.019","article-title":"Effects of berberine on diabetes induced by alloxan and a high-fat\/high-cholesterol diet in rats","volume":"108","author":"Tang","year":"2006","journal-title":"J Ethnopharmacol"},{"issue":"8","key":"10.1016\/j.mehy.2009.05.043_bib42","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.2337\/db06-0006","article-title":"Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states","volume":"55","author":"Lee","year":"2006","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.mehy.2009.05.043_bib43","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.bbagen.2006.09.007","article-title":"Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK","volume":"1760","author":"Cheng","year":"2006","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"10.1016\/j.mehy.2009.05.043_bib44","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1194\/jlr.M600020-JLR200","article-title":"Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine","volume":"47","author":"Brusq","year":"2006","journal-title":"J Lipid Res"},{"issue":"4","key":"10.1016\/j.mehy.2009.05.043_bib45","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1128\/MMBR.56.4.622-647.1992","article-title":"Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin","volume":"56","author":"Spangler","year":"1992","journal-title":"Microbiol Rev"},{"issue":"6","key":"10.1016\/j.mehy.2009.05.043_bib46","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.coph.2003.06.012","article-title":"CFTR pharmacology and its role in intestinal fluid secretion","volume":"3","author":"Thiagarajah","year":"2003","journal-title":"Curr Opin Pharmacol"},{"issue":"24","key":"10.1016\/j.mehy.2009.05.043_bib47","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/jnci\/93.24.1872","article-title":"Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention","volume":"93","author":"Chen","year":"2001","journal-title":"J Natl Cancer Inst"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987709003697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987709003697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T15:19:04Z","timestamp":1739200744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987709003697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0306987709003697"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2009.05.043","relation":{},"ISSN":["0306-9877"],"issn-type":[{"type":"print","value":"0306-9877"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}